ArticleMedical oncology (Northwood, London, England)2025
Evaluation of crizotinib as radiosensitizer in sacral chordoma cells: effects of combined carbon ion particle therapy.
Birgit Lohberger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.